118 related articles for article (PubMed ID: 10828836)
1. Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway.
Rey JM; Pujol P; Callier P; Cavailles V; Freiss G; Maudelonde T; Brouillet JP
J Mol Endocrinol; 2000 Jun; 24(3):433-40. PubMed ID: 10828836
[TBL] [Abstract][Full Text] [Related]
2. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
[TBL] [Abstract][Full Text] [Related]
3. Expression of nuclear receptors and cofactors in human endometrium and myometrium.
Vienonen A; Miettinen S; Bläuer M; Martikainen PM; Tomás E; Heinonen PK; Ylikomi T
J Soc Gynecol Investig; 2004 Feb; 11(2):104-12. PubMed ID: 14980312
[TBL] [Abstract][Full Text] [Related]
4. Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene.
Daverey A; Saxena R; Tewari S; Goel SK; Dwivedi A
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):93-101. PubMed ID: 19460436
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptor coregulators in normal and malignant human endometrium.
Kershah SM; Desouki MM; Koterba KL; Rowan BG
Gynecol Oncol; 2004 Jan; 92(1):304-13. PubMed ID: 14751175
[TBL] [Abstract][Full Text] [Related]
6. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.
Cavarretta IT; Mukopadhyay R; Lonard DM; Cowsert LM; Bennett CF; O'Malley BW; Smith CL
Mol Endocrinol; 2002 Feb; 16(2):253-70. PubMed ID: 11818499
[TBL] [Abstract][Full Text] [Related]
7. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
[TBL] [Abstract][Full Text] [Related]
9. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor cofactors expression in breast and endometrial human cancer cells.
Thenot S; Charpin M; Bonnet S; Cavailles V
Mol Cell Endocrinol; 1999 Oct; 156(1-2):85-93. PubMed ID: 10612426
[TBL] [Abstract][Full Text] [Related]
11. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
Schaufele F
Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nuclear receptor and cofactor expression in breast cancer cell lines.
Vienonen A; Miettinen S; Manninen T; Altucci L; Wilhelm E; Ylikomi T
Eur J Endocrinol; 2003 Apr; 148(4):469-79. PubMed ID: 12656669
[TBL] [Abstract][Full Text] [Related]
13. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
15. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the human NRIP1/RIP140 gene by estrogen is modulated by dioxin signalling.
Augereau P; Badia E; Fuentes M; Rabenoelina F; Corniou M; Derocq D; Balaguer P; Cavailles V
Mol Pharmacol; 2006 Apr; 69(4):1338-46. PubMed ID: 16391242
[TBL] [Abstract][Full Text] [Related]
19. Expression and hormonal regulation of coactivator and corepressor genes.
Misiti S; Schomburg L; Yen PM; Chin WW
Endocrinology; 1998 May; 139(5):2493-500. PubMed ID: 9564863
[TBL] [Abstract][Full Text] [Related]
20. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
Hussein-Fikret S; Fuller PJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
